388610 — Gfc Life Science Co Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeSmall Cap

Annual income statement for Gfc Life Science Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	ARS
Standards:	KAS	KAS	KAS	KAS
Status:	Final	Final	Final	Final
Revenue
Total Revenue	13,737	14,158	15,301	16,805
Cost of Revenue
Gross Profit	6,486	6,204	6,766	7,877
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	12,401	13,556	14,569	15,100
Operating Profit	1,336	603	732	1,705
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,657	234	469	-5,733
Provision for Income Taxes
Net Income After Taxes	1,641	327	1,437	-5,519
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	1,617	327	1,437	-5,519
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	1,617	327	1,367	-5,519
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	492	79.5	320	-1,872
Dividends per Share